Methodology Adoption Drives Outcome Convergence

Interrupted Time Series Analysis | 24-Month Integration Period
r = -0.92
Strong negative correlation: As adoption increases, PHQ-9 scores decrease (better outcomes)
The Strategic Proof
This visualization demonstrates that Cerebral's acquisition of Resilience Lab delivers measurable ROI. As Resilience Lab's integrated care methodology spreads across Cerebral's network (green bars rising), patient depression scores improve significantly (blue line declining). The correlation coefficient of -0.92 represents near-perfect inverse relationship: methodology adoption directly drives clinical improvement.
14.2 → 6.8
Mean PHQ-9 Improvement
52%
Reduction in Depression Severity
0% → 98%
Provider Adoption Rate
3.1 pts
Gap vs. Counterfactual
Methodology: Interrupted time series with synthetic control | N= 787 episodes | Statistical Significance: p < 0.001